Status:
COMPLETED
Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo
Lead Sponsor:
Butantan Institute
Conditions:
COVID
SARS-CoV 2
Eligibility:
All Genders
6-100 years
Brief Summary
Seroepidemiological Study of SARS-CoV-2 Infection in Population Subgroups in the State of São Paulo
Detailed Description
This is a cross-sectional study to estimate the prevalence of antibodies against SARS-CoV-2 is different population subgroups in the State of São Paulo
Eligibility Criteria
Inclusion
- All potential volunteers invited to participate in the study.
Exclusion
- All potential eligible participants, but who do not show interest in participating in the study.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2020
Estimated Enrollment :
18901 Patients enrolled
Trial Details
Trial ID
NCT04408014
Start Date
June 1 2020
End Date
July 30 2020
Last Update
February 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Avenida Vital Brasil 1500
São Paulo, Brazil, 05503-900